Allogeneic Cell Therapy Market is at USD 0.37 Billion, is estimated to grow at a CAGR of 24.5% in the forecasted period. The forecasted revenue hints at a growth of around 1.72 billion USD by 2029.


Report Scope:

The comprehensive Allogeneic Cell Therapy market study delves into competitive landscapes, offering insights into market share and company profiles of major global competitors. The research scope extends to a thorough analysis of the Allogeneic Cell Therapy Market, exploring factors contributing to regional growth disparities.

Research Methodology:

Employing a meticulous approach, market engineering involved statistical computations, size estimations, forecasts, breakdowns, and data triangulation. Extensive primary research validated critical figures, utilizing top-down and bottom-up strategies alongside diverse data triangulation methods. Qualitative and quantitative analyses of acquired data were integral to this process, ensuring vital information throughout the report.

For a free sample copy or to view the report summary, please visit: 

Identified through both primary and secondary research, market leaders were assessed, and revenue calculations were based on comprehensive interviews with key industry figures. In-depth discussions with frontline personnel, CEOs, and marketing executives formed primary research, while secondary research encompassed an examination of major manufacturers' annual and financial reports.


by Therapeutic Area

1.Haematological disorders
2.Dermatological disorders

by Indication

3.Cardiovascular Diseases

by End User

1.Biopharmaceuticals and Pharma companies
2.Research Organisations
3.Clinical Laboratories

by Type

1.Non stem cell
2.Stem Cell

Key Players: 

Key players in the Allogeneic Cell Therapy market, derived from primary and secondary research, contributed to market revenue calculations. Interviews with industry experts and a thorough review of manufacturers' reports informed this assessment.

1.Allogene Therapeutics - United States
2.Bluebird Bio - United States
3.Mustang Bio - United States
4.NantKwest - United States
5.Nkarta Therapeutics - United States
6. Precision BioSciences - United States
7. Sangamo Therapeutics - United States
8. TCR2 Therapeutics - United States
9. Unum Therapeutics - United States
10. WindMIL Therapeutics - United States
11. Gilead Sciences - United States
12. Iovance Biotherapeutics - United States
13.CRISPR Therapeutics - Switzerland
14. Gamida Cell - Israel
15. Iovance Biotherapeutics - United States
16.Kiadis Pharma - Netherlands
17. MaxCyte - United Kingdom
18. Adaptimmune Therapeutics - United Kingdom
19.Cellectis – France
20.Celyad – Belgium
21. Novartis - Switzerland
22. TC BioPharm - United Kingdom
23.Tessa Therapeutics – Singapore
24. Mesoblast – Australia
25. CARsgen Therapeutics - China

Know More About The Report: 

Regional Insights:

The Allogeneic Cell Therapy market analysis covers individual market influencers, encompassing changes in market laws and their impact on current and future trends. A comprehensive study of prevailing and future trends aims to evaluate overall market potential and discern profitable patterns. Geographical assessments are based on existing conditions and anticipated trends.

COVID-19 Impact Analysis:

The pandemic significantly impacted end-user sectors utilizing Allogeneic Cell Therapy , resulting in reduced growth across various countries. Lockdowns and global COVID-19 events led to decreased demand for Allogeneic Cell Therapy , affecting the market in 2029.

Key Questions Addressed:

The Allogeneic Cell Therapy Market Report addresses critical inquiries such as:

Dominant segment in the Allogeneic Cell Therapy market in 2029

Overview of the competitive landscape

Primary drivers fueling Allogeneic Cell Therapy market growth

Region with the highest market share

Expected CAGR of the Allogeneic Cell Therapy market during the projected period (2023-2029)

Get Enquiry: 


About Us
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

Our Address
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656